17-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof
US-2025376452-A1 · Dec 11, 2025 · US
having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07C307/10 |
| Official title | having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings |
| Display label | having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings |
| Total patents | 46 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Pyruvate kinase activators for use in therapy
US-2025332161-A1 · Oct 30, 2025 · US
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
US-12384753-B2 · Aug 12, 2025 · US
Pyruvate kinase activators for use in therapy
US-12377093-B2 · Aug 5, 2025 · US
Class of alkylphenol compounds and preparation method therefor
US-2024351966-A1 · Oct 24, 2024 · US
Pyruvate kinase activators for use in therapy
US-2024277701-A1 · Aug 22, 2024 · US
Arylamide derivative having antitumor activity
US-2024246922-A1 · Jul 25, 2024 · US
Arylamide derivative having antitumor activity
US-11964950-B2 · Apr 23, 2024 · US
Sulfonylureas and related compounds and use of same
US-11858922-B2 · Jan 2, 2024 · US
Pyruvate kinase activators for use in therapy
US-11793806-B2 · Oct 24, 2023 · US
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
US-2023143250-A1 · May 11, 2023 · US
Arylamide derivative having antitumor activity
US-2023002333-A1 · Jan 5, 2023 · US
Kcnt1 inhibitors and methods of use
US-2022280476-A1 · Sep 8, 2022 · US
Pyruvate kinase activators for use in therapy
US-2021220351-A1 · Jul 22, 2021 · US
Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease
US-10927075-B2 · Feb 23, 2021 · US
Sulfonylureas and related compounds and use of same
US-2020299284-A1 · Sep 24, 2020 · US
Pyruvate kinase activators for use in therapy
US-2020289502-A1 · Sep 17, 2020 · US
Pyruvate kinase activators for use in therapy
US-10632114-B2 · Apr 28, 2020 · US
Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives
US-2019359565-A1 · Nov 28, 2019 · US
Processes and intermediates for making sweet taste enhancers
US-2019263762-A1 · Aug 29, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07C307/10?
- CPC C07C307/10 is the Cooperative Patent Classification code for “having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings.”
- How many patents are filed under CPC C07C307/10 (having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings)?
- Our database includes 46 publications tagged with this CPC code.
- Is patent activity under CPC C07C307/10 growing?
- Publication counts under this code: 5 in 2024 vs 4 in 2025 (latest complete years).